SEC Tracker
Get the app

Cerus CERS

Cerus Q1 FY26: revenue $53.7M, up 24%; diluted EPS −$0.01

Form
10-Q
Filed
Period
Importance
Notable

Key figures from this report

These are the numbers Cerus reported for Q1 FY26, the quarter ended Mar 31, 2026, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Revenue$53.7M+24% from $43.2M in Q1 FY2510-Q income statement, on EDGAR
  2. Net income−$1.6MAgainst −$7.7M in Q1 FY2510-Q income statement, on EDGAR
  3. Diluted EPS−$0.01Against −$0.04 in Q1 FY2510-Q income statement, on EDGAR
  4. Cash and cash equivalents$27.9M+43% from $19.5M in Q1 FY25Cash and equivalents only; the company page adds short-term investments.10-Q balance sheet, on EDGAR
  5. Cash from operations−$3.0MAgainst −$844K in Q1 FY2510-Q cash flow statement, on EDGAR

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Cerus files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. SANUWAVE Health SNWV public float $233M, Jun 30, 2025
  2. Electromed ELMD public float $224M, Dec 31, 2025
  3. Tactile Systems Technology TCMD public float $223M, Jun 30, 2025
  4. Orasure Technologies OSUR public float $218M, Jun 30, 2025
  5. Heartflow HTFL